XQJ Stock Overview

Develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. More details

XQJ fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	0/6
Financial Health	3/6
Dividends	0/6

Risk Analysis

Shareholders have been substantially diluted in the past year

Does not have a meaningful market cap (€3M)

Volatile share price over the past 3 months compared to the German market

My Notes

Capture your thoughts, links and company narrative

China Pharma Holdings, Inc. Competitors

Biofrontera

XTRA:B8FK

€14.0m

SynBiotic

DUSE:SBX

€26.8m

TFF Pharmaceuticals

MUN:0K30

€9.7m

Cantourage Group

XTRA:HIGH

€63.0m

Price History & Performance

Summary of share price highs, lows and changes for China Pharma Holdings
Historical stock prices
Current Share Price	US$0.17
52 Week High	US$0.27
52 Week Low	US$0.17
Beta	0.66
1 Month Change	-13.24%
3 Month Change	-17.39%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-17.39%

Recent updates

Shareholder Returns

	XQJ	DE Pharmaceuticals	DE Market
7D	-7.6%	-2.2%	-2.0%
1Y	n/a	-15.6%	6.9%

Return vs Industry: Insufficient data to determine how XQJ performed against the German Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how XQJ performed against the German Market.

Price Volatility

Is XQJ's price volatile compared to industry and market?
XQJ volatility
XQJ Average Weekly Movement	11.0%
Pharmaceuticals Industry Average Movement	5.5%
Market Average Movement	4.9%
10% most volatile stocks in DE Market	11.3%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: XQJ's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine XQJ's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	231	Zhilin Li	www.chinapharmaholdings.com

China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Ozagrel Sodium to treat acute thrombotic cerebral infarction and dyskinesia; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection to treat edema diseases; and Candesartan for hypertension.

China Pharma Holdings, Inc. Fundamentals Summary

How do China Pharma Holdings's earnings and revenue compare to its market cap?
XQJ fundamental statistics
Market cap	€3.22m
Earnings (TTM)	-€4.56m
Revenue (TTM)	€5.33m

0.6x

P/S Ratio

-0.7x

P/E Ratio

Is XQJ overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
XQJ income statement (TTM)
Revenue	US$5.54m
Cost of Revenue	US$7.45m
Gross Profit	-US$1.90m
Other Expenses	US$2.84m
Earnings	-US$4.74m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.25
Gross Margin	-34.34%
Net Profit Margin	-85.56%
Debt/Equity Ratio	60.5%

How did XQJ perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/23 00:13
End of Day Share Price	2024/12/23 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

China Pharma Holdings, Inc. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Kevin DeGeeter	Ladenburg Thalmann & Company
Reni Benjamin	Rodman & Renshaw, LLC
Scott Henry	Roth MKM

China Pharma Holdings MUN:XQJ Stock Report